World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
QGENQiagen NV | $9.67bn | 26.18 | n/a |
RXDXPrometheus Biosciences | $9.56bn | n/a | n/a |
IMGNImmunoGen | $8.72bn | n/a | n/a |
VKTXViking Therapeutics | $8.12bn | n/a | n/a |
2269WuXi Biologics (Cayman) | HK$62.46bn | 17.31 | n/a |
LEGNLegend Biotech | $7.87bn | n/a | n/a |
ASNDAscendis Pharma A/S | $7.77bn | n/a | n/a |
CERECerevel Therapeutics Holdings | $7.69bn | n/a | n/a |
PCVXVaxcyte | $7.09bn | n/a | n/a |
BANBBACHEM HOLDING AG | CH₣6.25bn | 55.46 | 0.96% |
BPMCBlueprint Medicines | $6.68bn | n/a | n/a |
RETAReata Pharmaceuticals | $6.52bn | n/a | n/a |
CYTKCytokinetics | $6.49bn | n/a | n/a |
EXELExelixis | $6.22bn | 29.35 | n/a |
RVMDRevolution Medicines | $6.15bn | n/a | n/a |
ZEALZealand Pharma A/S | DKK40.95bn | n/a | n/a |
IONSIonis Pharmaceuticals | $5.70bn | n/a | n/a |
9926Akeso | HK$43.25bn | 19.06 | n/a |
ISEEIVERIC bio | $5.51bn | n/a | n/a |
IBRXImmunitybio | $5.50bn | n/a | n/a |